Journal Mobile Options
Table of Contents
Vol. 2, No. 3, 2009
Issue release date: October 2009
J Nutrigenet Nutrigenomics 2009;2:119–128

FADS Gene Cluster Polymorphisms: Important Modulators of Fatty Acid Levels and Their Impact on Atopic Diseases

Lattka E. · Illig T. · Heinrich J. · Koletzko B.
aInstitute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, and bDepartment of Pediatrics, Dr. von Hauner Children’s Hospital, University of Munich, Munich, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Long-chain polyunsaturated fatty acids (LC-PUFAs) play an important role in several physiological processes and their concentration in phospholipids has been associated with several complex diseases, such as atopic disease. The level and composition of LC-PUFAs in the human body is highly dependent on their intake in the diet or on the intake of fatty acid precursors, which are endogenously elongated and desaturated to physiologically active LC-PUFAs. The most important enzymes in this reaction cascade are the Δ5 and Δ6 desaturase. Several studies in the last few years have revealed that single nucleotide polymorphisms (SNPs) in the 2 desaturase encoding genes (FADS1 and FADS2) are highly associated with the concentration of ω–6 and ω–3 fatty acids, showing that beside nutrition, genetic factors also play an important role in the regulation of LC-PUFAs. This review focuses on current knowledge of the impact of genetic polymorphisms on LC-PUFA metabolism and on their potential role in the development of atopic diseases.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Duchen K, Bjorksten B: Polyunsaturated n–3 fatty acids and the development of atopic disease. Lipids 2001;36:1033–1042.
  2. Kompauer I, Demmelmair H, Koletzko B, Bolte G, Linseisen J, Heinrich J: Association of fatty acids in serum phospholipids with hay fever, specific and total immunoglobulin E. Br J Nutr 2005;93:529–535.
  3. Trak-Fellermeier MA, Brasche S, Winkler G, Koletzko B, Heinrich J: Food and fatty acid intake and atopic disease in adults. Eur Respir J 2004;23:575–582.
  4. Nakamura MT, Nara TY: Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004;24:345–376.
  5. Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jimenez M, Gil A, Rivero M, Veszpremi B, Decsi T, Koletzko BV: Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 2007;85:1392–1400.
  6. Koletzko B, Demmelmair H, Schaeffer L, Illig T, Heinrich J: Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements. Nestle Nutr Workshop Ser Pediatr Program 2008;62:35–49.
  7. Koletzko B, Larque E, Demmelmair H: Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J Perinat Med 2007;35(suppl 1):S5–S11.
  8. Larque E, Demmelmair H, Klingler M, De Jonge S, Bondy B, Koletzko B: Expression pattern of fatty acid transport protein-1 (FATP-1), FATP-4 and heart-fatty acid binding protein (H-FABP) genes in human term placenta. Early Hum Dev 2006;82:697–701.
  9. Koletzko B, Agostoni C, Carlson SE, Clandinin T, Hornstra G, Neuringer M, Uauy R, Yamashiro Y, Willatts P: Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr 2001;90:460–464.
  10. Dunstan JA, Prescott SL: Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Curr Opin Allergy Clin Immunol 2005;5:215–221.
  11. Field CJ, Thomson CA, Van Aerde JE, Parrott A, Euler A, Lien E, Clandinin MT: Lower proportion of CD45R0+ cells and deficient interleukin-10 production by for- mula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 2000;31:291–299.
  12. Cho HP, Nakamura MT, Clarke SD: Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem 1999;274:471–477.
  13. Cho HP, Nakamura M, Clarke SD: Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999;274:37335–37339.
  14. de Antueno RJ, Knickle LC, Smith H, Elliot ML, Allen SJ, Nwaka S, Winther MD: Activity of human delta5 and delta6 desaturases on multiple n–3 and n–6 polyunsaturated fatty acids. FEBS Lett 2001;509:77–80.
  15. Voss A, Reinhart M, Sankarappa S, Sprecher H: The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 1991;266:19995–20000.
  16. Geiger M, Mohammed BS, Sankarappa S, Sprecher H: Studies to determine if rat liver contains chain-length-specific acyl-CoA 6-desaturases. Biochim Biophys Acta 1993;1170:137–142.
  17. D’andrea S, Guillou H, Jan S, Catheline D, Thibault JN, Bouriel M, Rioux V, Legrand P: The same rat delta6-desaturase not only acts on 18- but also on 24-carbon fatty acids in very-long-chain polyunsaturated fatty acid biosynthesis. Biochem J 2002;364:49–55.
  18. Williard DE, Nwankwo JO, Kaduce TL, Harmon SD, Irons M, Moser HW, Raymond GV, Spector AA: Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. J Lipid Res 2001;42:501–508.
  19. Marzo I, Alava MA, Pineiro A, Naval J: Biosynthesis of docosahexaenoic acid in human cells: evidence that two different delta 6-desaturase activities may exist. Biochim Biophys Acta 1996;1301:263–272.

    External Resources

  20. Marzo I, Pineiro A, Naval J: Loss of delta6-desaturase activity leads to impaired docosahexaenoic acid synthesis in Y-79 retinoblastoma cells. Prostaglandins Leukot Essent Fatty Acids 1998;59:293–297.
  21. Marquardt A, Stohr H, White K, Weber BH: cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family. Genomics 2000;66:175–183.
  22. Park WJ, Kothapalli KS, Reardon HT, Kim LY, Brenna JT: Novel fatty acid desaturase 3 (FADS3) transcripts generated by alternative splicing. Gene 2009;446:28–34.
  23. Guillou H, Rioux V, Catheline D, Thibault JN, Bouriel M, Jan S, D’andrea S, Legrand P: Conversion of hexadecanoic acid to hexadecenoic acid by rat Delta 6-desaturase. J Lipid Res 2003;44:450–454.
  24. Rodriguez A, Sarda P, Nessmann C, Boulot P, Leger CL, Descomps B: Delta6- and delta5-desaturase activities in the human fetal liver: kinetic aspects. J Lipid Res 1998;39:1825–1832.
  25. Guillou H, D’andrea S, Rioux V, Jan S, Legrand P: The surprising diversity of delta6-desaturase substrates. Biochem Soc Trans 2004;32:86–87.
  26. Park WJ, Kothapalli KS, Lawrence P, Ty- burczy C, Brenna JT: An alternate pathway to long-chain polyunsaturates: the FADS2 gene product delta8-desaturates 20:2n–6 and 20:3n–3. J Lipid Res 2009;50:1195–1202.
  27. Stoffel W, Holz B, Jenke B, Binczek E, Gun-ter RH, Kiss C, Karakesisoglou I, Thevis M, Weber AA, Arnhold S, Addicks K: Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acids. EMBO J 2008;27:2281–2292.
  28. Stroud CK, Nara TY, Roqueta-Rivera M, Radlowski EC, Lawrence P, Zhang Y, Cho BH, Segre M, Hess RA, Brenna JT, Haschek WM, Nakamura MT: Disruption of FADS2 gene in mice impairs male reproduction and causes dermal and intestinal ulceration. J Lipid Res 2009, E-pub ahead of print.
  29. Schaeffer L, Gohlke H, Muller M, Heid IM, Palmer LJ, Kompauer I, Demmelmair H, Illig T, Koletzko B, Heinrich J: Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006;15:1745–1756.
  30. Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M, Cavallari U, Galavotti R, Martinelli N, Guarini P, Girelli D, Oli-vieri O, Corrocher R, Heinrich J, Pignatti PF, Illig T: SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008;43:289–299.
  31. Rzehak P, Heinrich J, Klopp N, Schaeffer L, Hoff S, Wolfram G, Illig T, Linseisen J: Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br J Nutr 2009;101:20–26.
  32. Xie L, Innis SM: Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n–6) and (n–3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 2008;138:2222–2228.
  33. Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, Guralnik JM, Singleton A, Bandinelli S, Cherubini A, Arnett D, Tsai MY, Ferrucci L: Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009;5:e1000338.
  34. Hansen AE: Serum lipids in eczema and in other pathologic conditions. Am J Dis Child 1937;53:933–946.
  35. Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL: Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 1984;110:643–648.
  36. Strannegard IL, Svennerholm L, Strannegard O: Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels. Int Arch Allergy Appl Immunol 1987;82:422–423.
  37. Oliwiecki S, Burton JL, Elles K, Horrobin DF: Levels of essential and other fatty acids in plasma and red cell phospholipids from normal controls and patients with atopic eczema. Acta Derm Venereol 1991;71:224–228.
  38. Griese M, Schur N, Laryea MD, Bremer HJ, Reinhardt D, Biggemann B: Fatty acid composition of phospholipids of plasma and of mononuclear blood cells in children with allergic asthma and the influence of glucocorticoids. Eur J Pediatr 1990;149:508–512.
  39. Leichsenring M, Kochsiek U, Paul K: (n–6)-fatty acids in plasma lipids of children with atopic bronchial asthma. Pediatr Allergy Immunol 1995;6:209–212.
  40. Yu G, Bjorksten B: Polyunsaturated fatty acids in school children in relation to allergy and serum IgE levels. Pediatr Allergy Immunol 1998;9:133–138.
  41. Rocklin RE, Thistle L, Gallant L, Manku MS, Horrobin D: Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma. Lipids 1986;21:17–20.
  42. Sakai K, Ueno K, Ogawa Y, Okuyama H: Fatty acid compositions of plasma lipids in young atopic patients. Chem Pharm Bull (Tokyo) 1986;34:2944–2949.
  43. Lindskov R, Holmer G: Polyunsaturated fatty acids in plasma, red blood cells and mononuclear cell phospholipids of patients with atopic dermatitis. Allergy 1992;47:517–521.
  44. Galli E, Picardo M, Chini L, Passi S, Moschese V, Terminali O, Paone F, Fraioli G, Rossi P: Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease? Br J Dermatol 1994;130:752–756.
  45. Yu G, Kjellman NI, Bjorksten B: Phospholipid fatty acids in cord blood: family history and development of allergy. Acta Paediatr 1996;85:679–683.
  46. Beck M, Zelczak G, Lentze MJ: Abnormal fatty acid composition in umbilical cord blood of infants at high risk of atopic disease. Acta Paediatr 2000;89:279–284.
  47. Duchen K, Casas R, Fageras-Bottcher M, Yu G, Bjorksten B: Human milk polyunsaturated long-chain fatty acids and secretory immunoglobulin A antibodies and early childhood allergy. Pediatr Allergy Immunol 2000;11:29–39.
  48. Yu G, Bjorksten B: Serum levels of phospholipid fatty acids in mothers and their babies in relation to allergic disease. Eur J Pediatr 1998;157:298–303.
  49. Manku MS, Horrobin DF, Morse N, Kyte V, Jenkins K, Wright S, Burton JL: Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot Med 1982;9:615–628.
  50. Lans DM, Rocklin RE: Dysregulation of arachidonic acid release and metabolism by atopic mononuclear cells. Clin Exp Allergy 1989;19:37–44.
  51. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB: Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69–102.
  52. Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K, Iikura Y, Awaji T, Tsujimoto G, Yanagida M, Uzumaki H, Takahashi G, Tsuji K, Nakahata T: Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157:343–350.
  53. Roper RL, Brown DM, Phipps RP: Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE. J Immunol 1995;154:162–170.
  54. Aloisi F, Penna G, Cerase J, Menendez IB, Adorini L: IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol 1997;159:1604–1612.
  55. Demeure CE, Yang LP, Desjardins C, Raynauld P, Delespesse G: Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur J Immunol 1997;27:3526–3531.
  56. Dugas N, Dugas B, Kolb JP, Yamaoka K, Delfraiss JF, Damais C: Role of leukotriene B4 in the interleukin-4-induced human mononuclear phagocyte activation. Immunology 1996;88:384–388.
  57. Khalfoun B, Thibault G, Lacord M, Gruel Y, Bardos P, Lebranchu Y: Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers. Scand J Immunol 1996;43:248–256.
  58. Simopoulos AP: Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438–463.
  59. Stafford AN, Rider SH, Hopkin JM, Cookson WO, Monaco AP: A 2.8 Mb YAC contig in 11q12-q13 localizes candidate genes for atopy: Fc epsilon RI beta and CD20. Hum Mol Genet 1994;3:779–785.
  60. Wheatley AP, Bolland DJ, Hewitt JE, Dewar JC, Hall IP: Identification of the autoantigen SART-1 as a candidate gene for the development of atopy. Hum Mol Genet 2002;11:2143–2146.
  61. Kramer MS: Does breast feeding help protect against atopic disease? Biology, methodology, and a golden jubilee of controversy. J Pediatr 1988;112:181–190.
  62. Yu G, Duchen K, Bjorksten B: Fatty acid composition in colostrum and mature milk from non-atopic and atopic mothers during the first 6 months of lactation. Acta Paediatr 1998;87:729–736.
  63. Thijs C, Houwelingen A, Poorterman I, Mordant A, van den BP: Essential fatty acids in breast milk of atopic mothers: comparison with non-atopic mothers, and effect of borage oil supplementation. Eur J Clin Nutr 2000;54:234–238.
  64. Wright S, Bolton C: Breast milk fatty acids in mothers of children with atopic eczema. Br J Nutr 1989;62:693–697.
  65. Businco L, Ioppi M, Morse NL, Nisini R, Wright S: Breast milk from mothers of children with newly developed atopic eczema has low levels of long chain polyunsaturated fatty acids. J Allergy Clin Immunol 1993;91:1134–1139.
  66. Luukkainen P, Salo MK, Nikkari T: Changes in the fatty acid composition of preterm and term human milk from 1 week to 6 months of lactation. J Pediatr Gastroenterol Nutr 1994;18:355–360.
  67. Biagi PL, Hrelia S, Celadon M, Turchetto E, Masi M, Ricci G, Specchia F, Cannella MV, Horrobin DF, Bordoni A: Erythrocyte membrane fatty acid composition in children with atopic dermatitis compared to age-matched controls. Acta Paediatr 1993;82:789–790.
  68. Luukkainen P, Salo MK, Visakorpi JK, Raiha NC, Nikkari T: Impact of solid food on plasma arachidonic and docosahexaenoic acid status of term infants at 8 months of age. J Pediatr Gastroenterol Nutr 1996;23:229–234.
  69. Ponder DL, Innis SM, Benson JD, Siegman JS: Docosahexaenoic acid status of term infants fed breast milk or infant formula containing soy oil or corn oil. Pediatr Res 1992;32:683–688.
  70. Akeson PM, Axelsson IE, Raiha NC: Plasma lipids and apolipoproteins in breastfed and formula-fed Swedish infants. Acta Paediatr 1999;88:1–6.
  71. Fidler N, Sauerwald T, Pohl A, Demmelmair H, Koletzko B: Docosahexaenoic acid transfer into human milk after dietary supplementation: a randomized clinical trial. J Lipid Res 2000;41:1376–1383.
  72. Marangoni F, Agostoni C, Lammardo AM, Bonvissuto M, Giovannini M, Galli C, Riva E: Polyunsaturated fatty acids in maternal plasma and in breast milk. Prostaglandins Leukot Essent Fatty Acids 2002;66:535–540.
  73. Lattka E, Eggers S, Moeller G, Heim K, Weber M, Mehta D, Prokisch H, Illig T, Adamski J: A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor ELK1. J Lipid Res 2009, E-pub ahead of print.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50